Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mandy Wootton is active.

Publication


Featured researches published by Mandy Wootton.


Antimicrobial Agents and Chemotherapy | 2005

Strain-Specific Expression Levels of pbp4 Exist in Isolates of Glycopeptide-Intermediate Staphylococcus aureus (GISA) and Heterogeneous GISA

Mandy Wootton; Peter M. Bennett; Alasdair P. MacGowan; Timothy R. Walsh

A common characteristic of glycopeptide-intermediate-resistant Staphylococcus aureus (GISA) is a thickened cell wall, containing fewer cross-links and hence an abundance of d-Ala-d-Ala termini of the pentapeptide. A further phenomenon observed in GISA has been lowered or nonexistent expression of


Archives of Disease in Childhood | 2018

G96(P) Are white cells in children’s urine diagnostic or a distraction, and does collection and culture method matter? new data from 4910 acutely unwell children

S Alam; J van der Voort; Mandy Wootton; B Creswell; Alastair D Hay; Christopher Collett Butler

Aims To describe the relationship between urine white cell count (WCC) and the microbiological diagnosis of UTI in acutely unwell children, and explore the influence of culture and collection method. Methods Multi-centre, prospective, cohort study of acutely unwell children aged 3 months-5 years presenting to UK primary care whose urine samples were collected by clean catch or nappy pad, and cultured by both a Central Laboratory (CL) using spiral-plating, and Local NHS Laboratories (LL) using standard practice. Positive and negative predictive values (PPV and NPV) of diagnosing UTI were calculated for WCC ≥100/mm3 and WCC ≤10/mm3 respectively, comparing laboratories and sampling methods. Results Of 4910 samples, 1.9% had UTI in the CL and 5.3% in the LL. Table 1 outlines the PPV of WCC ≥100/mm3 and NPV of WCC ≤10/mm3 for diagnosing UTI by laboratory culture and sampling method. Abstract G96(P) Table 1 CL culture LL culture All Samples Clean Catch Nappy Pad All Samples Clean Catch Nappy Pad PPV of WCC≥ 100/mm3 23.9 % [17.5–31.6%] 33.3 % [25.0–42.8%] 0 30.3 % [22.7–39.1%] 38.7 % [29.3–49.0%] 6.9 % [1.8–23.6%] NPV of WCC≤ 10/mm3 99.0 % [98.7–99.2%] 99.3 % [98.9–99.5%] 98.6 % [98.3–98.9%] 95.8 % [95.4–96.2%] 97.7 % [97.2–98.2%] 93.6 % [92.9–94.2%] Conclusions Local NHS Labs diagnose almost 3x more UTIs than a reference Central Laboratory. Many of these may be false positives. A WCC ≥100/mm3 poorly predicts UTI on culture in acutely unwell young children consulting in primary care. Despite WCC≤10/mm3 having a good NPV regardless of collection or culture method, 37 of the 92 positive CL cultures (40%) had WCC≤10/mm3. Recommendation We propose a diagnostic algorithm selectively utilising spiral-plating culture methods to potentially minimise unnecessary treatment and investigation for 9000 children per year across England and Wales.


Journal of Antimicrobial Chemotherapy | 2001

A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital

Mandy Wootton; Ra Howe; R. Hillman; Timothy R. Walsh; Peter M. Bennett; A. P. MacGowan


Journal of Antimicrobial Chemotherapy | 1999

The antibacterial efficacy of levofloxacin and ciprofloxacin against Pseudomonas aeruginosa assessed by combining antibiotic exposure and bacterial susceptibility.

Alasdair P. MacGowan; Mandy Wootton; H. Alan Holt


Journal of Antimicrobial Chemotherapy | 1997

Bay 12-8039, a new 8-methoxy-quinolone: comparative in-vitro activity with nine other antimicrobials against anaerobic bacteria.

A. P. MacGowan; K. E. Bowker; H. A. Holt; Mandy Wootton; D. S. Reeves


Antimicrobial Agents and Chemotherapy | 1999

Activity of Moxifloxacin, Administered Once a Day, against Streptococcus pneumoniae in an In Vitro Pharmacodynamic Model of Infection

Alasdair P. MacGowan; K. E. Bowker; Mandy Wootton; H. Alan Holt


Clinical Microbiology and Infection | 1999

In vitro assessment of colistin's antipseudomonal antimicrobial interactions with other antibiotics.

Alasdair P. MacGowan; Caroline Rynn; Mandy Wootton; K. E. Bowker; H. Alan Holt; David S. Reeves


Journal of Antimicrobial Chemotherapy | 1999

In-vitro activity of HMR 3647 against Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and β-haemolytic streptococci

Mandy Wootton; K. E. Bowker; A. Janowska; H. A. Holt; Alasdair P. MacGowan


Journal of Antimicrobial Chemotherapy | 2002

BAL 9141, a new broad-spectrum pyrrolidinone cephalosporin: activity against clinically significant anaerobes in comparison with 10 other antimicrobials

Mandy Wootton; K. E. Bowker; H. A. Holt; A. P. MacGowan


Journal of Antimicrobial Chemotherapy | 1999

Comparison of in-vitro pharmacodynamics of once and twice daily ciprofloxacin

K. E. Bowker; Mandy Wootton; Chris A. Rogers; Roger J. Lewis; H. A. Holt; A. P. MacGowan

Collaboration


Dive into the Mandy Wootton's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Paul Little

University of Southampton

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jan Dudley

Bristol Royal Hospital for Children

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kate Rumsby

University of Southampton

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge